Keywords: USA, Authorized generics, Congress, ANDA, HPM

Legislation to ban authorized generics during 180-day exclusivity makes a comeback in Congress

Article | 23 February 2011

Last week, substantively identical legislation was introduced in both the US House of Representatives and in the Senate to amend ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in